Finally, confirmation about when milestone payments are due.
~A$14m to come on FDA acceptance of the NDA. With 60 days provided for FDA decision on whether to accept an NDA for review, that means September, if the NDA is submitted in July.
The second payment of ~A$55m is due on first sale of trofinetide. If Acadia moves with the same speed as they did with pimavanserin, that could occur as early as 1 to 2 months of FDA approval.
Ann: 2021 Results - a transformational year for Neuren, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.36 |
Change
-0.210(1.44%) |
Mkt cap ! $1.787B | |||
| Open | High | Low | Value | Volume |
| $14.50 | $14.56 | $14.16 | $3.192M | 222.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35 | $14.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.40 | 2800 | 2 |
View Market Depth
| Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |